ERBB2 and breast cancer: In another study, Liu et al. demonstrated that NK-92 cells expressing an erbB2-specific CAR could significantly prolong the survival of mice inoculated with erbB2+ breast cancer cells and induce the loss of the primary tumor and lung metastases [123].